Figure 2
From: A 41-gene signature derived from breast cancer stem cells as a predictor of survival
Kaplan-Meier analysis of the probability that patients would remain free of distant metastasis among all patients. A. prediction value of DMFS by the 41-gene signature. Patients were divided into those with a good-prognostic signature and those with a poor prognostic signature according to gene-expression profiling; B. prediction value of OS by AOL consensus criteria; C. prediction value of DMFS by NPI consensus criteria; D. prediction value of DMFS by St. Gallen criteria; E. prediction of Veridex signature. The p values were calculated by log-rank test.